Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
24.14 USD | -2.43% | +0.50% | +25.48% |
Apr. 10 | Baird Raises Owens & Minor's Price Target to $28 From $24, Maintains Neutral Rating | MT |
Feb. 29 | Owens & Minor Insider Sold Shares Worth $250,000, According to a Recent SEC Filing | MT |
Summary
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
Strengths
- The earnings growth currently anticipated by analysts for the coming years is particularly strong.
- The stock, which is currently worth 2024 to 0.33 times its sales, is clearly overvalued in comparison with peers.
- Given the positive cash flows generated by its business, the company's valuation level is an asset.
- For the past twelve months, EPS forecast has been revised upwards.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
Weaknesses
- With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- Low profitability weakens the company.
- With an expected P/E ratio at 164.93 and 27.29 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+25.48% | 1.9B | B+ | ||
-3.99% | 9.41B | B+ | ||
-5.82% | 1.39B | D | ||
-10.04% | 1.18B | - | ||
-18.54% | 859M | - | - | |
+0.57% | 486M | - | ||
+3.85% | 439M | - | - | |
-49.21% | 339M | - | ||
-25.59% | 325M | - | - | |
-2.51% | 217M | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- OMI Stock
- Ratings Owens & Minor, Inc.